BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang Y, Zhang D, Li L, Xin T, Zhao Y, Ma R, Du J. Exosomal microRNA-144 from bone marrow-derived mesenchymal stem cells inhibits the progression of non-small cell lung cancer by targeting CCNE1 and CCNE2. Stem Cell Res Ther 2020;11:87. [PMID: 32102682 DOI: 10.1186/s13287-020-1580-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Luo T, von der Ohe J, Hass R. MSC-Derived Extracellular Vesicles in Tumors and Therapy. Cancers (Basel) 2021;13:5212. [PMID: 34680359 DOI: 10.3390/cancers13205212] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Silva M, Monteiro GA, Fialho AM, Bernardes N, da Silva CL. Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines. Front Cell Dev Biol 2020;8:471. [PMID: 32733876 DOI: 10.3389/fcell.2020.00471] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Wang H, Huang H, Wang L, Liu Y, Wang M, Zhao S, Lu G, Kang X. Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer. Aging (Albany NY) 2021;13:14456-68. [PMID: 33999859 DOI: 10.18632/aging.103556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li D, Wang Y, Jin X, Hu D, Xia C, Xu H, Hu J. NK cell-derived exosomes carry miR-207 and alleviate depression-like symptoms in mice.J Neuroinflammation. 2020;17:126. [PMID: 32321532 DOI: 10.1186/s12974-020-01787-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
5 Jothimani G, Pathak S, Dutta S, Duttaroy AK, Banerjee A. A Comprehensive Cancer-Associated MicroRNA Expression Profiling and Proteomic Analysis of Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes. Tissue Eng Regen Med 2022. [PMID: 35511336 DOI: 10.1007/s13770-022-00450-8] [Reference Citation Analysis]
6 Guo Q, Xiao X, Wu C, Li D, Chen J, Ding X, Cheng C, Chen C, Tong S, Wang S. Clinical Roles of Risk Model Based on Differentially Expressed Genes in Mesenchymal Stem Cells in Prognosis and Immunity of Non-small Cell Lung Cancer. Front Genet 2022;13:823075. [DOI: 10.3389/fgene.2022.823075] [Reference Citation Analysis]
7 Zhang R, Yang F, Fan H, Wang H, Wang Q, Yang J, Song T. Long non-coding RNA TUG1/microRNA-187-3p/TESC axis modulates progression of pituitary adenoma via regulating the NF-κB signaling pathway. Cell Death Dis 2021;12:524. [PMID: 34021124 DOI: 10.1038/s41419-021-03812-7] [Reference Citation Analysis]
8 Yuan J, Wei Z, Xu X, Ocansey DKW, Cai X, Mao F. The Effects of Mesenchymal Stem Cell on Colorectal Cancer. Stem Cells Int 2021;2021:9136583. [PMID: 34349805 DOI: 10.1155/2021/9136583] [Reference Citation Analysis]
9 Lv H, Yu J, Zhang H, Qian X, Wang Q, Lu B, Sun Y. MicroRNA-631 deriving from bone marrow mesenchymal stem cell exosomes facilitates the malignant behavior of non-small cell lung cancer via modulating the E2F family of transcription factor 2/phosphatidylinositol 3-kinase/Akt signaling pathway. Bioengineered 2022;13:8382-95. [PMID: 35353027 DOI: 10.1080/21655979.2022.2036891] [Reference Citation Analysis]
10 Sinha D, Roy S, Saha P, Chatterjee N, Bishayee A. Trends in Research on Exosomes in Cancer Progression and Anticancer Therapy. Cancers (Basel) 2021;13:326. [PMID: 33477340 DOI: 10.3390/cancers13020326] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
11 Zhao S, Li W, Yu W, Rao T, Li H, Ruan Y, Yuan R, Li C, Ning J, Li S, Chen W, Cheng F, Zhou X. Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys. Theranostics 2021;11:8660-73. [PMID: 34522205 DOI: 10.7150/thno.62820] [Reference Citation Analysis]
12 Li D, Lin F, Li G, Zeng F. Exosomes derived from mesenchymal stem cells curbs the progression of clear cell renal cell carcinoma through T-cell immune response. Cytotechnology 2021;73:593-604. [PMID: 34349349 DOI: 10.1007/s10616-021-00480-5] [Reference Citation Analysis]
13 Zhu K, Ge J, He Y, Li P, Jiang X, Wang J, Mo Y, Huang W, Gong Z, Zeng Z, Xiong W, Yu J. Bioinformatics Analysis of the Signaling Pathways and Genes of Gossypol Induce Death of Nasopharyngeal Carcinoma Cells. DNA Cell Biol 2021;40:1052-63. [PMID: 34191589 DOI: 10.1089/dna.2020.6348] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Wu S, Pan Y, Mao Y, Chen Y, He Y. Current progress and mechanisms of bone metastasis in lung cancer: a narrative review. Transl Lung Cancer Res 2021;10:439-51. [PMID: 33569325 DOI: 10.21037/tlcr-20-835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Li W, Xin X, Li X, Geng J, Sun Y. Exosomes secreted by M2 macrophages promote cancer stemness of hepatocellular carcinoma via the miR-27a-3p/TXNIP pathways. Int Immunopharmacol 2021;101:107585. [PMID: 34601333 DOI: 10.1016/j.intimp.2021.107585] [Reference Citation Analysis]
16 Zhou M, Wu Y, Li H, Zha X. MicroRNA-144: A novel biological marker and potential therapeutic target in human solid cancers. J Cancer 2020;11:6716-26. [PMID: 33046994 DOI: 10.7150/jca.46293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Sharma V, Aggarwal A, Jacob J, Sahni D. Myeloid-derived suppressor cells: Bridging the gap between inflammation and pancreatic adenocarcinoma. Scand J Immunol 2021;93:e13021. [PMID: 33455004 DOI: 10.1111/sji.13021] [Reference Citation Analysis]
18 Lin S, Lin W, Liao C, Zhou T. Nephroprotective Effect of Mesenchymal Stem Cell-Based Therapy of Kidney Disease Induced by Toxicants. Stem Cells Int 2020;2020:8819757. [PMID: 33424979 DOI: 10.1155/2020/8819757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Saha P, Datta S, Ghosh S, Samanta A, Ghosh P, Sinha D. Bioengineering of Extracellular Vesicles: Exosome-Based Next-Generation Therapeutic Strategy in Cancer. Bioengineering (Basel) 2021;8:139. [PMID: 34677212 DOI: 10.3390/bioengineering8100139] [Reference Citation Analysis]
20 Cao XH, Liang MX, Wu Y, Yang K, Tang JH, Zhang W. Extracellular vesicles as drug vectors for precise cancer treatment. Nanomedicine (Lond) 2021;16:1519-37. [PMID: 34011162 DOI: 10.2217/nnm-2021-0123] [Reference Citation Analysis]
21 Sanmartin MC, Borzone FR, Giorello MB, Yannarelli G, Chasseing NA. Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Biological Carriers for Drug Delivery in Cancer Therapy. Front Bioeng Biotechnol 2022;10:882545. [DOI: 10.3389/fbioe.2022.882545] [Reference Citation Analysis]
22 Zhao J, Lin H, Huang K. Mesenchymal Stem Cell-derived Extracellular Vesicles Transmitting MicroRNA-34a-5p Suppress Tumorigenesis of Colorectal Cancer Through c-MYC/DNMT3a/PTEN Axis. Mol Neurobiol 2021. [PMID: 34623601 DOI: 10.1007/s12035-021-02431-9] [Reference Citation Analysis]
23 Xing L, Tang X, Wu K, Huang X, Yi Y, Huan J. LncRNA HAND2-AS1 suppressed the growth of triple negative breast cancer via reducing secretion of MSCs derived exosomal miR-106a-5p. Aging (Albany NY) 2020;13:424-36. [PMID: 33290256 DOI: 10.18632/aging.202148] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Tian W, Yang H, Zhou B. Integrative analysis of exosomal microRNA-149-5p in lung adenocarcinoma. Aging (Albany NY) 2021;13:7382-96. [PMID: 33658392 DOI: 10.18632/aging.202596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]